Annals of Oncology · 2009 · 1.4K citations · 55 references
MedicineEndocrinologyOncologyBreast OncologyChemotherapyMolecular OncologyAdjuvant TherapyBreast Cancer OncologyHer2-positive Breast CancerHormonal Cancer TherapyHormonal TherapyAdjuvant Hormonal TherapyBreast Cancer Hormonal TherapyEstrogen Receptor ExpressionEstrogen Receptor StatusHormone Receptor-positive Breast Cancer TherapyPredictive Tumor MarkersTherapeutic Decision-makingTreatment Modality Selection
55
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer et al. · New England Journal of Medicine · 2002 · 6.5K citations · Full text
Medicine, Bioinformatics, Oncology +17
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text
Medicine, Oncology, Pharmacology +16
Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text